Guided Therapeutics Inc (GTHP)

[GetSeriousOK]

There's the S-1. This answers all three of your questions but we all know that won't matter.

The filing of the S-1 isn't going to budge the PPS because nobody reads SEC filings. However, it is a momentous event. It proves that Gene is serious about keeping this boat above water, and it means Guided will now get funding to complete the clinical trials.

I skimmed the S-1 but it doesn't tell us anything we didn't already know. 40 million new shares are being registered. Some of these shares were already issued in December, and many will only be issued upon conversion of the Series D Preferred and/or Series E Preferred, which realistically won't happen for awhile, especially the shares priced at 75 cents.

Regarding SMI: officially, SMI has until the end of January 2021 to get CFDA approval or they turn to dust (18 months from July 24, 2019). I gave up on SMI last summer, but we can all officially give up on SMI in five months. Buh bye, SMI.